NKTX vs PSA · $188.9M cap vs rev $1.23B
Nkarta Inc (NKTX) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
PSA (PSA) common stock.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
NKTX currently screens at market cap $188.9M. PSA currently screens at market cap $0.
Not investment advice. Open the NKTX and PSA stock pages for the full models.
Not investment advice.